Pharmaceutical Products Price Equity Act

Fact Sheet API

Bill Number

HR 1574

Introduced

Apr 24, 2001

Latest Action

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Sponsor

Cosponsors

Topics

Administrative procedure Administrative remedies Civil actions and liability Class actions (Civil procedure) Commerce Crime and Law Enforcement Damages Drug industry Economics and Public Finance Fines (Penalties) Government Operations and Politics Health Injunctions Law Legal fees Prescription pricing Price discrimination Price regulation Punitive damages

Full Text

View Full Bill Text

Votes

Summary

Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.

Actions

Sep 28, 2001

Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.
May 4, 2001

Referred to the Subcommittee on Health.
Apr 24, 2001

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 24, 2001

Introduced in House

Amendments

Related Bills